nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—asthma—atopic dermatitis	0.676	1	CtDrD
Arformoterol—CYP2A6—Prednisolone—atopic dermatitis	0.0322	0.16	CbGbCtD
Arformoterol—CYP2C19—Loratadine—atopic dermatitis	0.0227	0.112	CbGbCtD
Arformoterol—CYP2C19—Diphenhydramine—atopic dermatitis	0.0227	0.112	CbGbCtD
Arformoterol—CYP2A6—Dexamethasone—atopic dermatitis	0.019	0.0941	CbGbCtD
Arformoterol—CYP2C9—Loratadine—atopic dermatitis	0.0189	0.0935	CbGbCtD
Arformoterol—CYP2C9—Diphenhydramine—atopic dermatitis	0.0189	0.0935	CbGbCtD
Arformoterol—CYP2D6—Loratadine—atopic dermatitis	0.0172	0.0855	CbGbCtD
Arformoterol—CYP2D6—Diphenhydramine—atopic dermatitis	0.0172	0.0855	CbGbCtD
Arformoterol—CYP2C19—Prednisone—atopic dermatitis	0.0126	0.0623	CbGbCtD
Arformoterol—CYP2C19—Dexamethasone—atopic dermatitis	0.00784	0.0389	CbGbCtD
Arformoterol—CYP2C9—Dexamethasone—atopic dermatitis	0.00652	0.0324	CbGbCtD
Arformoterol—CYP2D6—Dexamethasone—atopic dermatitis	0.00596	0.0296	CbGbCtD
Arformoterol—Nausea—Mometasone—atopic dermatitis	6.63e-05	0.000541	CcSEcCtD
Arformoterol—Immune system disorder—Methylprednisolone—atopic dermatitis	6.62e-05	0.00054	CcSEcCtD
Arformoterol—Mediastinal disorder—Methylprednisolone—atopic dermatitis	6.6e-05	0.000539	CcSEcCtD
Arformoterol—Arrhythmia—Triamcinolone—atopic dermatitis	6.56e-05	0.000536	CcSEcCtD
Arformoterol—Arrhythmia—Methylprednisolone—atopic dermatitis	6.55e-05	0.000534	CcSEcCtD
Arformoterol—Hypersensitivity—Tacrolimus—atopic dermatitis	6.54e-05	0.000534	CcSEcCtD
Arformoterol—Hyperglycaemia—Prednisone—atopic dermatitis	6.54e-05	0.000534	CcSEcCtD
Arformoterol—Ill-defined disorder—Prednisolone—atopic dermatitis	6.45e-05	0.000527	CcSEcCtD
Arformoterol—Visual impairment—Betamethasone—atopic dermatitis	6.42e-05	0.000524	CcSEcCtD
Arformoterol—Visual impairment—Dexamethasone—atopic dermatitis	6.42e-05	0.000524	CcSEcCtD
Arformoterol—Mental disorder—Methylprednisolone—atopic dermatitis	6.42e-05	0.000524	CcSEcCtD
Arformoterol—Malnutrition—Methylprednisolone—atopic dermatitis	6.38e-05	0.000521	CcSEcCtD
Arformoterol—Asthenia—Tacrolimus—atopic dermatitis	6.37e-05	0.00052	CcSEcCtD
Arformoterol—Acute coronary syndrome—Prednisone—atopic dermatitis	6.37e-05	0.00052	CcSEcCtD
Arformoterol—Angioedema—Prednisolone—atopic dermatitis	6.35e-05	0.000519	CcSEcCtD
Arformoterol—Myocardial infarction—Prednisone—atopic dermatitis	6.34e-05	0.000517	CcSEcCtD
Arformoterol—Ill-defined disorder—Hydrocortisone—atopic dermatitis	6.3e-05	0.000514	CcSEcCtD
Arformoterol—Pruritus—Tacrolimus—atopic dermatitis	6.28e-05	0.000513	CcSEcCtD
Arformoterol—Malaise—Prednisolone—atopic dermatitis	6.27e-05	0.000512	CcSEcCtD
Arformoterol—Dysgeusia—Triamcinolone—atopic dermatitis	6.26e-05	0.000511	CcSEcCtD
Arformoterol—Angioedema—Hydrocortisone—atopic dermatitis	6.2e-05	0.000506	CcSEcCtD
Arformoterol—Back pain—Triamcinolone—atopic dermatitis	6.18e-05	0.000505	CcSEcCtD
Arformoterol—Malaise—Hydrocortisone—atopic dermatitis	6.12e-05	0.0005	CcSEcCtD
Arformoterol—Diarrhoea—Tacrolimus—atopic dermatitis	6.08e-05	0.000496	CcSEcCtD
Arformoterol—Hypertension—Prednisolone—atopic dermatitis	6e-05	0.00049	CcSEcCtD
Arformoterol—Arrhythmia—Dexamethasone—atopic dermatitis	5.95e-05	0.000486	CcSEcCtD
Arformoterol—Arrhythmia—Betamethasone—atopic dermatitis	5.95e-05	0.000486	CcSEcCtD
Arformoterol—Ill-defined disorder—Triamcinolone—atopic dermatitis	5.93e-05	0.000484	CcSEcCtD
Arformoterol—Ill-defined disorder—Methylprednisolone—atopic dermatitis	5.92e-05	0.000483	CcSEcCtD
Arformoterol—Dizziness—Tacrolimus—atopic dermatitis	5.87e-05	0.00048	CcSEcCtD
Arformoterol—Hypertension—Hydrocortisone—atopic dermatitis	5.86e-05	0.000479	CcSEcCtD
Arformoterol—Discomfort—Prednisolone—atopic dermatitis	5.85e-05	0.000477	CcSEcCtD
Arformoterol—Angioedema—Triamcinolone—atopic dermatitis	5.84e-05	0.000477	CcSEcCtD
Arformoterol—Angioedema—Methylprednisolone—atopic dermatitis	5.83e-05	0.000476	CcSEcCtD
Arformoterol—Myalgia—Hydrocortisone—atopic dermatitis	5.78e-05	0.000472	CcSEcCtD
Arformoterol—Malaise—Triamcinolone—atopic dermatitis	5.77e-05	0.000471	CcSEcCtD
Arformoterol—Anxiety—Hydrocortisone—atopic dermatitis	5.76e-05	0.00047	CcSEcCtD
Arformoterol—Malaise—Methylprednisolone—atopic dermatitis	5.75e-05	0.00047	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	5.74e-05	0.000469	CcSEcCtD
Arformoterol—Discomfort—Hydrocortisone—atopic dermatitis	5.71e-05	0.000466	CcSEcCtD
Arformoterol—Connective tissue disorder—Prednisone—atopic dermatitis	5.7e-05	0.000466	CcSEcCtD
Arformoterol—Anaphylactic shock—Prednisolone—atopic dermatitis	5.67e-05	0.000463	CcSEcCtD
Arformoterol—Oedema—Prednisolone—atopic dermatitis	5.67e-05	0.000463	CcSEcCtD
Arformoterol—Vomiting—Tacrolimus—atopic dermatitis	5.65e-05	0.000461	CcSEcCtD
Arformoterol—Rash—Tacrolimus—atopic dermatitis	5.6e-05	0.000457	CcSEcCtD
Arformoterol—Dermatitis—Tacrolimus—atopic dermatitis	5.6e-05	0.000457	CcSEcCtD
Arformoterol—Cough—Triamcinolone—atopic dermatitis	5.58e-05	0.000455	CcSEcCtD
Arformoterol—Headache—Tacrolimus—atopic dermatitis	5.56e-05	0.000454	CcSEcCtD
Arformoterol—Anaphylactic shock—Hydrocortisone—atopic dermatitis	5.54e-05	0.000452	CcSEcCtD
Arformoterol—Oedema—Hydrocortisone—atopic dermatitis	5.54e-05	0.000452	CcSEcCtD
Arformoterol—Tachycardia—Prednisolone—atopic dermatitis	5.54e-05	0.000452	CcSEcCtD
Arformoterol—Hypertension—Triamcinolone—atopic dermatitis	5.52e-05	0.000451	CcSEcCtD
Arformoterol—Hypertension—Methylprednisolone—atopic dermatitis	5.51e-05	0.00045	CcSEcCtD
Arformoterol—Infection—Hydrocortisone—atopic dermatitis	5.51e-05	0.000449	CcSEcCtD
Arformoterol—Myalgia—Triamcinolone—atopic dermatitis	5.44e-05	0.000444	CcSEcCtD
Arformoterol—Nervous system disorder—Hydrocortisone—atopic dermatitis	5.43e-05	0.000444	CcSEcCtD
Arformoterol—Arthralgia—Methylprednisolone—atopic dermatitis	5.43e-05	0.000443	CcSEcCtD
Arformoterol—Myalgia—Methylprednisolone—atopic dermatitis	5.43e-05	0.000443	CcSEcCtD
Arformoterol—Anxiety—Methylprednisolone—atopic dermatitis	5.41e-05	0.000442	CcSEcCtD
Arformoterol—Tachycardia—Hydrocortisone—atopic dermatitis	5.41e-05	0.000442	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	5.39e-05	0.00044	CcSEcCtD
Arformoterol—Skin disorder—Hydrocortisone—atopic dermatitis	5.38e-05	0.000439	CcSEcCtD
Arformoterol—Ill-defined disorder—Betamethasone—atopic dermatitis	5.38e-05	0.000439	CcSEcCtD
Arformoterol—Ill-defined disorder—Dexamethasone—atopic dermatitis	5.38e-05	0.000439	CcSEcCtD
Arformoterol—Discomfort—Triamcinolone—atopic dermatitis	5.38e-05	0.000439	CcSEcCtD
Arformoterol—Discomfort—Methylprednisolone—atopic dermatitis	5.37e-05	0.000438	CcSEcCtD
Arformoterol—Dry mouth—Triamcinolone—atopic dermatitis	5.32e-05	0.000435	CcSEcCtD
Arformoterol—Angioedema—Dexamethasone—atopic dermatitis	5.3e-05	0.000433	CcSEcCtD
Arformoterol—Angioedema—Betamethasone—atopic dermatitis	5.3e-05	0.000433	CcSEcCtD
Arformoterol—Nausea—Tacrolimus—atopic dermatitis	5.28e-05	0.000431	CcSEcCtD
Arformoterol—Immune system disorder—Prednisone—atopic dermatitis	5.24e-05	0.000428	CcSEcCtD
Arformoterol—Malaise—Dexamethasone—atopic dermatitis	5.23e-05	0.000427	CcSEcCtD
Arformoterol—Malaise—Betamethasone—atopic dermatitis	5.23e-05	0.000427	CcSEcCtD
Arformoterol—Anaphylactic shock—Triamcinolone—atopic dermatitis	5.22e-05	0.000426	CcSEcCtD
Arformoterol—Oedema—Triamcinolone—atopic dermatitis	5.22e-05	0.000426	CcSEcCtD
Arformoterol—Anaphylactic shock—Methylprednisolone—atopic dermatitis	5.21e-05	0.000425	CcSEcCtD
Arformoterol—Arrhythmia—Prednisone—atopic dermatitis	5.18e-05	0.000423	CcSEcCtD
Arformoterol—Infection—Triamcinolone—atopic dermatitis	5.18e-05	0.000423	CcSEcCtD
Arformoterol—Hypotension—Hydrocortisone—atopic dermatitis	5.18e-05	0.000423	CcSEcCtD
Arformoterol—Infection—Methylprednisolone—atopic dermatitis	5.17e-05	0.000422	CcSEcCtD
Arformoterol—Insomnia—Prednisolone—atopic dermatitis	5.13e-05	0.000419	CcSEcCtD
Arformoterol—Nervous system disorder—Methylprednisolone—atopic dermatitis	5.11e-05	0.000417	CcSEcCtD
Arformoterol—Tachycardia—Triamcinolone—atopic dermatitis	5.09e-05	0.000416	CcSEcCtD
Arformoterol—Mental disorder—Prednisone—atopic dermatitis	5.08e-05	0.000415	CcSEcCtD
Arformoterol—Tachycardia—Methylprednisolone—atopic dermatitis	5.08e-05	0.000415	CcSEcCtD
Arformoterol—Skin disorder—Methylprednisolone—atopic dermatitis	5.06e-05	0.000413	CcSEcCtD
Arformoterol—Malnutrition—Prednisone—atopic dermatitis	5.05e-05	0.000412	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	5.05e-05	0.000412	CcSEcCtD
Arformoterol—Insomnia—Hydrocortisone—atopic dermatitis	5.01e-05	0.000409	CcSEcCtD
Arformoterol—Hypertension—Dexamethasone—atopic dermatitis	5.01e-05	0.000409	CcSEcCtD
Arformoterol—Hypertension—Betamethasone—atopic dermatitis	5.01e-05	0.000409	CcSEcCtD
Arformoterol—Myalgia—Betamethasone—atopic dermatitis	4.94e-05	0.000403	CcSEcCtD
Arformoterol—Myalgia—Dexamethasone—atopic dermatitis	4.94e-05	0.000403	CcSEcCtD
Arformoterol—Anxiety—Dexamethasone—atopic dermatitis	4.92e-05	0.000402	CcSEcCtD
Arformoterol—Anxiety—Betamethasone—atopic dermatitis	4.92e-05	0.000402	CcSEcCtD
Arformoterol—Discomfort—Betamethasone—atopic dermatitis	4.88e-05	0.000398	CcSEcCtD
Arformoterol—Discomfort—Dexamethasone—atopic dermatitis	4.88e-05	0.000398	CcSEcCtD
Arformoterol—Dyspepsia—Hydrocortisone—atopic dermatitis	4.88e-05	0.000398	CcSEcCtD
Arformoterol—Hypotension—Methylprednisolone—atopic dermatitis	4.86e-05	0.000397	CcSEcCtD
Arformoterol—Pain—Prednisolone—atopic dermatitis	4.85e-05	0.000396	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	4.78e-05	0.000391	CcSEcCtD
Arformoterol—Fatigue—Hydrocortisone—atopic dermatitis	4.78e-05	0.00039	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	4.75e-05	0.000388	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	4.74e-05	0.000387	CcSEcCtD
Arformoterol—Pain—Hydrocortisone—atopic dermatitis	4.74e-05	0.000387	CcSEcCtD
Arformoterol—Oedema—Betamethasone—atopic dermatitis	4.73e-05	0.000386	CcSEcCtD
Arformoterol—Anaphylactic shock—Dexamethasone—atopic dermatitis	4.73e-05	0.000386	CcSEcCtD
Arformoterol—Anaphylactic shock—Betamethasone—atopic dermatitis	4.73e-05	0.000386	CcSEcCtD
Arformoterol—Oedema—Dexamethasone—atopic dermatitis	4.73e-05	0.000386	CcSEcCtD
Arformoterol—Insomnia—Triamcinolone—atopic dermatitis	4.72e-05	0.000385	CcSEcCtD
Arformoterol—Insomnia—Methylprednisolone—atopic dermatitis	4.71e-05	0.000384	CcSEcCtD
Arformoterol—Infection—Dexamethasone—atopic dermatitis	4.7e-05	0.000384	CcSEcCtD
Arformoterol—Infection—Betamethasone—atopic dermatitis	4.7e-05	0.000384	CcSEcCtD
Arformoterol—Ill-defined disorder—Prednisone—atopic dermatitis	4.69e-05	0.000383	CcSEcCtD
Arformoterol—Feeling abnormal—Prednisolone—atopic dermatitis	4.68e-05	0.000382	CcSEcCtD
Arformoterol—Dyspnoea—Triamcinolone—atopic dermatitis	4.65e-05	0.00038	CcSEcCtD
Arformoterol—Nervous system disorder—Betamethasone—atopic dermatitis	4.64e-05	0.000379	CcSEcCtD
Arformoterol—Nervous system disorder—Dexamethasone—atopic dermatitis	4.64e-05	0.000379	CcSEcCtD
Arformoterol—Agitation—Prednisone—atopic dermatitis	4.64e-05	0.000379	CcSEcCtD
Arformoterol—Tachycardia—Betamethasone—atopic dermatitis	4.62e-05	0.000377	CcSEcCtD
Arformoterol—Tachycardia—Dexamethasone—atopic dermatitis	4.62e-05	0.000377	CcSEcCtD
Arformoterol—Angioedema—Prednisone—atopic dermatitis	4.62e-05	0.000377	CcSEcCtD
Arformoterol—Dyspepsia—Triamcinolone—atopic dermatitis	4.59e-05	0.000375	CcSEcCtD
Arformoterol—Dyspepsia—Methylprednisolone—atopic dermatitis	4.58e-05	0.000374	CcSEcCtD
Arformoterol—Feeling abnormal—Hydrocortisone—atopic dermatitis	4.57e-05	0.000373	CcSEcCtD
Arformoterol—Malaise—Prednisone—atopic dermatitis	4.56e-05	0.000372	CcSEcCtD
Arformoterol—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	4.53e-05	0.00037	CcSEcCtD
Arformoterol—Urticaria—Prednisolone—atopic dermatitis	4.51e-05	0.000368	CcSEcCtD
Arformoterol—Fatigue—Triamcinolone—atopic dermatitis	4.5e-05	0.000367	CcSEcCtD
Arformoterol—Fatigue—Methylprednisolone—atopic dermatitis	4.49e-05	0.000366	CcSEcCtD
Arformoterol—Pain—Triamcinolone—atopic dermatitis	4.46e-05	0.000364	CcSEcCtD
Arformoterol—Hypotension—Betamethasone—atopic dermatitis	4.42e-05	0.000361	CcSEcCtD
Arformoterol—Hypotension—Dexamethasone—atopic dermatitis	4.42e-05	0.000361	CcSEcCtD
Arformoterol—Urticaria—Hydrocortisone—atopic dermatitis	4.4e-05	0.000359	CcSEcCtD
Arformoterol—Body temperature increased—Hydrocortisone—atopic dermatitis	4.38e-05	0.000358	CcSEcCtD
Arformoterol—Abdominal pain—Hydrocortisone—atopic dermatitis	4.38e-05	0.000358	CcSEcCtD
Arformoterol—Hypertension—Prednisone—atopic dermatitis	4.36e-05	0.000356	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	4.31e-05	0.000352	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	4.31e-05	0.000352	CcSEcCtD
Arformoterol—Arthralgia—Prednisone—atopic dermatitis	4.3e-05	0.000351	CcSEcCtD
Arformoterol—Myalgia—Prednisone—atopic dermatitis	4.3e-05	0.000351	CcSEcCtD
Arformoterol—Feeling abnormal—Triamcinolone—atopic dermatitis	4.3e-05	0.000351	CcSEcCtD
Arformoterol—Feeling abnormal—Methylprednisolone—atopic dermatitis	4.29e-05	0.00035	CcSEcCtD
Arformoterol—Anxiety—Prednisone—atopic dermatitis	4.29e-05	0.00035	CcSEcCtD
Arformoterol—Insomnia—Dexamethasone—atopic dermatitis	4.28e-05	0.00035	CcSEcCtD
Arformoterol—Insomnia—Betamethasone—atopic dermatitis	4.28e-05	0.00035	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	4.27e-05	0.000349	CcSEcCtD
Arformoterol—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	4.26e-05	0.000348	CcSEcCtD
Arformoterol—Discomfort—Prednisone—atopic dermatitis	4.25e-05	0.000347	CcSEcCtD
Arformoterol—Hypersensitivity—Prednisolone—atopic dermatitis	4.18e-05	0.000341	CcSEcCtD
Arformoterol—Dyspepsia—Betamethasone—atopic dermatitis	4.17e-05	0.00034	CcSEcCtD
Arformoterol—Dyspepsia—Dexamethasone—atopic dermatitis	4.17e-05	0.00034	CcSEcCtD
Arformoterol—Urticaria—Triamcinolone—atopic dermatitis	4.14e-05	0.000338	CcSEcCtD
Arformoterol—Urticaria—Methylprednisolone—atopic dermatitis	4.14e-05	0.000338	CcSEcCtD
Arformoterol—Body temperature increased—Triamcinolone—atopic dermatitis	4.12e-05	0.000337	CcSEcCtD
Arformoterol—Anaphylactic shock—Prednisone—atopic dermatitis	4.12e-05	0.000337	CcSEcCtD
Arformoterol—Oedema—Prednisone—atopic dermatitis	4.12e-05	0.000337	CcSEcCtD
Arformoterol—Abdominal pain—Methylprednisolone—atopic dermatitis	4.12e-05	0.000336	CcSEcCtD
Arformoterol—Infection—Prednisone—atopic dermatitis	4.1e-05	0.000334	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Betamethasone—atopic dermatitis	4.09e-05	0.000334	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	4.09e-05	0.000334	CcSEcCtD
Arformoterol—Hypersensitivity—Hydrocortisone—atopic dermatitis	4.08e-05	0.000333	CcSEcCtD
Arformoterol—Fatigue—Dexamethasone—atopic dermatitis	4.08e-05	0.000333	CcSEcCtD
Arformoterol—Fatigue—Betamethasone—atopic dermatitis	4.08e-05	0.000333	CcSEcCtD
Arformoterol—Pain—Dexamethasone—atopic dermatitis	4.05e-05	0.000331	CcSEcCtD
Arformoterol—Pain—Betamethasone—atopic dermatitis	4.05e-05	0.000331	CcSEcCtD
Arformoterol—Nervous system disorder—Prednisone—atopic dermatitis	4.04e-05	0.00033	CcSEcCtD
Arformoterol—Tachycardia—Prednisone—atopic dermatitis	4.02e-05	0.000328	CcSEcCtD
Arformoterol—Skin disorder—Prednisone—atopic dermatitis	4e-05	0.000327	CcSEcCtD
Arformoterol—Asthenia—Hydrocortisone—atopic dermatitis	3.98e-05	0.000325	CcSEcCtD
Arformoterol—Pruritus—Hydrocortisone—atopic dermatitis	3.92e-05	0.00032	CcSEcCtD
Arformoterol—Feeling abnormal—Dexamethasone—atopic dermatitis	3.9e-05	0.000318	CcSEcCtD
Arformoterol—Feeling abnormal—Betamethasone—atopic dermatitis	3.9e-05	0.000318	CcSEcCtD
Arformoterol—Gastrointestinal pain—Betamethasone—atopic dermatitis	3.87e-05	0.000316	CcSEcCtD
Arformoterol—Gastrointestinal pain—Dexamethasone—atopic dermatitis	3.87e-05	0.000316	CcSEcCtD
Arformoterol—Hypersensitivity—Triamcinolone—atopic dermatitis	3.84e-05	0.000314	CcSEcCtD
Arformoterol—Hypersensitivity—Methylprednisolone—atopic dermatitis	3.84e-05	0.000313	CcSEcCtD
Arformoterol—Diarrhoea—Hydrocortisone—atopic dermatitis	3.79e-05	0.00031	CcSEcCtD
Arformoterol—Urticaria—Dexamethasone—atopic dermatitis	3.76e-05	0.000307	CcSEcCtD
Arformoterol—Urticaria—Betamethasone—atopic dermatitis	3.76e-05	0.000307	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Prednisone—atopic dermatitis	3.76e-05	0.000307	CcSEcCtD
Arformoterol—Dizziness—Prednisolone—atopic dermatitis	3.75e-05	0.000306	CcSEcCtD
Arformoterol—Asthenia—Triamcinolone—atopic dermatitis	3.74e-05	0.000306	CcSEcCtD
Arformoterol—Body temperature increased—Betamethasone—atopic dermatitis	3.74e-05	0.000306	CcSEcCtD
Arformoterol—Body temperature increased—Dexamethasone—atopic dermatitis	3.74e-05	0.000306	CcSEcCtD
Arformoterol—Abdominal pain—Betamethasone—atopic dermatitis	3.74e-05	0.000306	CcSEcCtD
Arformoterol—Abdominal pain—Dexamethasone—atopic dermatitis	3.74e-05	0.000306	CcSEcCtD
Arformoterol—Asthenia—Methylprednisolone—atopic dermatitis	3.74e-05	0.000305	CcSEcCtD
Arformoterol—Insomnia—Prednisone—atopic dermatitis	3.73e-05	0.000304	CcSEcCtD
Arformoterol—Pruritus—Triamcinolone—atopic dermatitis	3.69e-05	0.000301	CcSEcCtD
Arformoterol—Pruritus—Methylprednisolone—atopic dermatitis	3.68e-05	0.000301	CcSEcCtD
Arformoterol—Dizziness—Hydrocortisone—atopic dermatitis	3.66e-05	0.000299	CcSEcCtD
Arformoterol—Dyspepsia—Prednisone—atopic dermatitis	3.63e-05	0.000296	CcSEcCtD
Arformoterol—Rash—Prednisolone—atopic dermatitis	3.58e-05	0.000292	CcSEcCtD
Arformoterol—Dermatitis—Prednisolone—atopic dermatitis	3.57e-05	0.000292	CcSEcCtD
Arformoterol—Diarrhoea—Methylprednisolone—atopic dermatitis	3.56e-05	0.000291	CcSEcCtD
Arformoterol—Fatigue—Prednisone—atopic dermatitis	3.55e-05	0.00029	CcSEcCtD
Arformoterol—Headache—Prednisolone—atopic dermatitis	3.55e-05	0.00029	CcSEcCtD
Arformoterol—Constipation—Prednisone—atopic dermatitis	3.53e-05	0.000288	CcSEcCtD
Arformoterol—Vomiting—Hydrocortisone—atopic dermatitis	3.52e-05	0.000288	CcSEcCtD
Arformoterol—Rash—Hydrocortisone—atopic dermatitis	3.49e-05	0.000285	CcSEcCtD
Arformoterol—Dermatitis—Hydrocortisone—atopic dermatitis	3.49e-05	0.000285	CcSEcCtD
Arformoterol—Headache—Hydrocortisone—atopic dermatitis	3.47e-05	0.000283	CcSEcCtD
Arformoterol—Dizziness—Triamcinolone—atopic dermatitis	3.45e-05	0.000282	CcSEcCtD
Arformoterol—Dizziness—Methylprednisolone—atopic dermatitis	3.44e-05	0.000281	CcSEcCtD
Arformoterol—Feeling abnormal—Prednisone—atopic dermatitis	3.4e-05	0.000277	CcSEcCtD
Arformoterol—Asthenia—Betamethasone—atopic dermatitis	3.4e-05	0.000277	CcSEcCtD
Arformoterol—Asthenia—Dexamethasone—atopic dermatitis	3.4e-05	0.000277	CcSEcCtD
Arformoterol—Gastrointestinal pain—Prednisone—atopic dermatitis	3.37e-05	0.000275	CcSEcCtD
Arformoterol—Nausea—Prednisolone—atopic dermatitis	3.37e-05	0.000275	CcSEcCtD
Arformoterol—Pruritus—Dexamethasone—atopic dermatitis	3.35e-05	0.000273	CcSEcCtD
Arformoterol—Pruritus—Betamethasone—atopic dermatitis	3.35e-05	0.000273	CcSEcCtD
Arformoterol—Vomiting—Triamcinolone—atopic dermatitis	3.32e-05	0.000271	CcSEcCtD
Arformoterol—Vomiting—Methylprednisolone—atopic dermatitis	3.31e-05	0.00027	CcSEcCtD
Arformoterol—Nausea—Hydrocortisone—atopic dermatitis	3.29e-05	0.000269	CcSEcCtD
Arformoterol—Rash—Triamcinolone—atopic dermatitis	3.29e-05	0.000269	CcSEcCtD
Arformoterol—Dermatitis—Triamcinolone—atopic dermatitis	3.29e-05	0.000268	CcSEcCtD
Arformoterol—Rash—Methylprednisolone—atopic dermatitis	3.28e-05	0.000268	CcSEcCtD
Arformoterol—Dermatitis—Methylprednisolone—atopic dermatitis	3.28e-05	0.000268	CcSEcCtD
Arformoterol—Urticaria—Prednisone—atopic dermatitis	3.28e-05	0.000267	CcSEcCtD
Arformoterol—Headache—Triamcinolone—atopic dermatitis	3.27e-05	0.000267	CcSEcCtD
Arformoterol—Headache—Methylprednisolone—atopic dermatitis	3.26e-05	0.000266	CcSEcCtD
Arformoterol—Abdominal pain—Prednisone—atopic dermatitis	3.26e-05	0.000266	CcSEcCtD
Arformoterol—Body temperature increased—Prednisone—atopic dermatitis	3.26e-05	0.000266	CcSEcCtD
Arformoterol—Diarrhoea—Betamethasone—atopic dermatitis	3.24e-05	0.000264	CcSEcCtD
Arformoterol—Diarrhoea—Dexamethasone—atopic dermatitis	3.24e-05	0.000264	CcSEcCtD
Arformoterol—Dizziness—Dexamethasone—atopic dermatitis	3.13e-05	0.000256	CcSEcCtD
Arformoterol—Dizziness—Betamethasone—atopic dermatitis	3.13e-05	0.000256	CcSEcCtD
Arformoterol—Nausea—Triamcinolone—atopic dermatitis	3.1e-05	0.000253	CcSEcCtD
Arformoterol—Nausea—Methylprednisolone—atopic dermatitis	3.09e-05	0.000252	CcSEcCtD
Arformoterol—Hypersensitivity—Prednisone—atopic dermatitis	3.04e-05	0.000248	CcSEcCtD
Arformoterol—Vomiting—Betamethasone—atopic dermatitis	3.01e-05	0.000246	CcSEcCtD
Arformoterol—Vomiting—Dexamethasone—atopic dermatitis	3.01e-05	0.000246	CcSEcCtD
Arformoterol—Rash—Betamethasone—atopic dermatitis	2.99e-05	0.000244	CcSEcCtD
Arformoterol—Rash—Dexamethasone—atopic dermatitis	2.99e-05	0.000244	CcSEcCtD
Arformoterol—Dermatitis—Betamethasone—atopic dermatitis	2.98e-05	0.000243	CcSEcCtD
Arformoterol—Dermatitis—Dexamethasone—atopic dermatitis	2.98e-05	0.000243	CcSEcCtD
Arformoterol—Headache—Betamethasone—atopic dermatitis	2.97e-05	0.000242	CcSEcCtD
Arformoterol—Headache—Dexamethasone—atopic dermatitis	2.97e-05	0.000242	CcSEcCtD
Arformoterol—Asthenia—Prednisone—atopic dermatitis	2.96e-05	0.000241	CcSEcCtD
Arformoterol—Pruritus—Prednisone—atopic dermatitis	2.92e-05	0.000238	CcSEcCtD
Arformoterol—Diarrhoea—Prednisone—atopic dermatitis	2.82e-05	0.00023	CcSEcCtD
Arformoterol—Nausea—Dexamethasone—atopic dermatitis	2.81e-05	0.00023	CcSEcCtD
Arformoterol—Nausea—Betamethasone—atopic dermatitis	2.81e-05	0.00023	CcSEcCtD
Arformoterol—Dizziness—Prednisone—atopic dermatitis	2.73e-05	0.000223	CcSEcCtD
Arformoterol—Vomiting—Prednisone—atopic dermatitis	2.62e-05	0.000214	CcSEcCtD
Arformoterol—Rash—Prednisone—atopic dermatitis	2.6e-05	0.000212	CcSEcCtD
Arformoterol—Dermatitis—Prednisone—atopic dermatitis	2.6e-05	0.000212	CcSEcCtD
Arformoterol—Headache—Prednisone—atopic dermatitis	2.58e-05	0.000211	CcSEcCtD
Arformoterol—Nausea—Prednisone—atopic dermatitis	2.45e-05	0.0002	CcSEcCtD
